Skip To Main Content
Barbara Seliger on Muck Rack

Barbara Seliger

As seen in: Color Research & Application, Nature, MDPI, The BMJ, Expert Review of Anticancer Therapy, Journal of Translational Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer - Journal of Translational Medicine

|
By Martin Luther Halle-Wittenberg, Martin-Luther Universität Halle-Wittenberg, Kim Iv, Udo Siebolts, Marcus Bauer, Christoforos Vaxevanis, Antonios Asiminas, Kerstin Lorenz, Christine Dierks, Claudia Wickenhauser, Barbara Seliger, Mario Udinotti
| Journal of Translational Medicine Verified
TC cell lines of distinct subtypes were kindly provided by Prof. Dr. Cuong Hoàng-Vu (Laboratory Surgical Research, University Hospital Halle, Halle, Germany, and Prof. Dr. Stefan Huettelmaier, Medical Faculty of the Martin Luther University Halle-Wittenberg, Institute for Molecular Medicine, Section Molecular Cell Biology, Halle, Germany).
Open in Who Shared Issue with article?

HIV status alters immune cell infiltration and activation profile in women with breast cancer - Nature Communications

|
By Pablo Santos, Martina Vetter, Wenlong Chen, Barbara Seliger, Nivashini Murugan
| Nature Verified
Abstract The breast cancer (BC)-related mortality is higher and the immunity is altered in women living with HIV (WLWH) compared to HIV-negative women. Therefore, tumor samples of 296 black BC patients from South Africa and Namibia with known age, HIV status, tumor stage, hormone receptor and HER2 status and overall survival (OS) are analyzed for components of the tumor microenvironment (TME).
Open in Who Shared Issue with article?

Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy

|
By Michael Bachmann, Barbara Seliger, Helmholtz-Zentrum Dresden-Rossendorf, Christoforos Vaxevanis
| The BMJ Verified
Clinical relevance of immune modulatory miRNAs Based on the differential expression pattern in tumors, the use of im-miRNAs as diagnostic and/or prognostic tools for various cancer types to predict patients’ outcome has been investigated.107 In addition, the clinical relevance of im-miRNAs was demonstrated based on the targeted pathway and their relevance in the respective cancer type.
Open in Who Shared Issue with article?
See all 10 articles